This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Clozapine is the prototype atypical antipsychotic drug. The term atypical antipsychotic refers to drugs that do not cause catalepsy in animals, have a minor or no effect on plasma prolactin, do not cause extrapyramidal symptoms in humans, do not cause tardive dyskinesia, are effective in the treatment of negative symptoms, and may be effective in nonresponders to classical neuroleptics. We have previously demonstrated in positron emission tomography (PET) studies that clozapine is atypical also with regard to the degree of striatal D₂ dopamine receptor occupancy during clinical treatment. While all classical antipsychotic drugs occupied 70% to 90% of the striatal D₂ receptors, the D₂ occupancy during clozapine treatment was significantly lower (20%-67%).¹ The maximal D₂ occupancy during clinical treatment with clozapine at very high plasma concentrations was estimated to be about 60%.²

Olanzapine is a new antipsychotic that has been put forward as an atypical antipsychotic drug, based on preclinical . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors
Vazquez-Borsetti et al.
Cereb Cortex 2009;19:1678-1686.
ABSTRACT | FULL TEXT  

The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors: A Positron Emission Tomography Study With [11C]-(+)-PHNO
Graff-Guerrero et al.
Arch Gen Psychiatry 2009;66:606-615.
ABSTRACT | FULL TEXT  

Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia
Woods et al.
Arch Gen Psychiatry 2005;62:961-970.
ABSTRACT | FULL TEXT  

Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine
Moresco et al.
J Psychopharmacol 2004;18:355-365.
ABSTRACT  

"Special Scrutiny": A Targeted Form of Research Protocol Review
Levine et al.
ANN INTERN MED 2004;140:220-223.
ABSTRACT | FULL TEXT  

Subjective Experience and D2 Receptor Occupancy in Patients With Recent-Onset Schizophrenia Treated With Low-Dose Olanzapine or Haloperidol: A Randomized, Double-Blind Study
de Haan et al.
Am. J. Psychiatry 2003;160:303-309.
ABSTRACT | FULL TEXT  

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study
Meisenzahl et al.
J Psychopharmacol 2000;14:364-370.
ABSTRACT